These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38597415)

  • 61. Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinoma.
    Yang Q; Zhu W; Gong H
    Front Immunol; 2023; 14():1148483. PubMed ID: 37077919
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of an Amino Acid Metabolism-Related Gene Signature for Predicting Prognosis in Lung Adenocarcinoma.
    Chang W; Li H; Wu C; Zhong L; Zhu T; Chang Z; Ou W; Wang S
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553562
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Single-cell and Bulk RNA-Seq reveal angiogenic heterogeneity and microenvironmental features to evaluate prognosis and therapeutic response in lung adenocarcinoma.
    Tang L; Chen Z; Yang J; Li Q; Wang S; Mo T; Zeng W; Ding H; Pan S
    Front Immunol; 2024; 15():1352893. PubMed ID: 38390340
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts.
    Ren Q; Zhang P; Lin H; Feng Y; Chi H; Zhang X; Xia Z; Cai H; Yu Y
    Front Immunol; 2023; 14():1201573. PubMed ID: 37325647
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vasculogenic mimicry-associated novel gene signature predicted prognosis and response to immunotherapy in lung adenocarcinoma.
    Zhang L; Wu J; Yin WW; Hu J; Liao L; Ma J; Xu Z; Wu S
    Pathol Res Pract; 2024 Jan; 253():155048. PubMed ID: 38147724
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma.
    Jia H; Tang WJ; Sun L; Wan C; Zhou Y; Shen WZ
    Front Genet; 2022; 13():1017866. PubMed ID: 36699466
    [No Abstract]   [Full Text] [Related]  

  • 67. A Novel Nucleic Acid Sensing-related Genes Signature for Predicting Immunotherapy Efficacy and Prognosis of Lung Adenocarcinoma.
    Peng X; Wu H; Zhang B; Xu C; Lang J
    Curr Cancer Drug Targets; 2024; 24(4):425-444. PubMed ID: 37592781
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation.
    Wang Y; Xu Y; Liu C; Yuan C; Zhang Y
    Front Immunol; 2023; 14():1233260. PubMed ID: 37799714
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A New Prognostic Indicator of Immune Microenvironment and Therapeutic Response in Lung Adenocarcinoma Based on Peroxisome-Related Genes.
    Xiong Z; Zhang L; Fan W
    J Immunol Res; 2022; 2022():6084589. PubMed ID: 35935579
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Profiles of Immune Infiltration and Prognostic Immunoscore in Lung Adenocarcinoma.
    Li Y; Tao L; Cai W
    Biomed Res Int; 2020; 2020():5858092. PubMed ID: 32596334
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of Cancer Stem Cell-related Gene by Single-cell and Machine Learning Predicts Immune Status, Chemotherapy Drug, and Prognosis in Lung Adenocarcinoma.
    Yang C; Zhang J; Xie J; Li L; Zhao X; Liu J; Wang X
    Curr Stem Cell Res Ther; 2024; 19(5):767-780. PubMed ID: 37455453
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma.
    Zhang W; Li Y; Lyu J; Shi F; Kong Y; Sheng C; Wang S; Wang Q
    Cancer Sci; 2022 Mar; 113(3):891-903. PubMed ID: 34967077
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comprehensive analysis of co-expressed genes with TDP-43: prognostic and therapeutic potential in lung adenocarcinoma.
    Zhang H; Lin J; Yahaya BH
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):44. PubMed ID: 38281298
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Machine learning reveals two heterogeneous subtypes to assist immune therapy based on lipid metabolism in lung adenocarcinoma.
    Gu X; Wei S; Li Z; Xu H
    Front Immunol; 2022; 13():1022149. PubMed ID: 36238302
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma.
    Zhang P; Wang W; Liu L; Li H; Sha X; Wang S; Huang Z; Zhou Y; Shi J
    Sci Rep; 2022 Dec; 12(1):22077. PubMed ID: 36543847
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genomic and immunogenomic analysis of three prognostic signature genes in LUAD.
    Feng HM; Zhao Y; Yan WJ; Li B
    BMC Bioinformatics; 2023 Jan; 24(1):19. PubMed ID: 36650426
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic model of lung adenocarcinoma constructed by the CENPA complex genes is closely related to immune infiltration.
    Zhou H; Bian T; Qian L; Zhao C; Zhang W; Zheng M; Zhou H; Liu L; Sun H; Li X; Zhang J; Liu Y
    Pathol Res Pract; 2021 Dec; 228():153680. PubMed ID: 34798483
    [TBL] [Abstract][Full Text] [Related]  

  • 78. KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden.
    Marinelli D; Mazzotta M; Scalera S; Terrenato I; Sperati F; D'Ambrosio L; Pallocca M; Corleone G; Krasniqi E; Pizzuti L; Barba M; Carpano S; Vici P; Filetti M; Giusti R; Vecchione A; Occhipinti M; Gelibter A; Botticelli A; De Nicola F; Ciuffreda L; Goeman F; Gallo E; Visca P; Pescarmona E; Fanciulli M; De Maria R; Marchetti P; Ciliberto G; Maugeri-Saccà M
    Ann Oncol; 2020 Dec; 31(12):1746-1754. PubMed ID: 32866624
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment.
    Wu XN; Su D; Mei YD; Xu MQ; Zhang H; Wang ZY; Li LL; Peng L; Jiang JY; Yang JY; Li DJ; Cao H; Xia ZW; Zeng WJ; Cheng Q; Zhang N
    Cancer Immunol Immunother; 2021 Oct; 70(10):2835-2850. PubMed ID: 33659999
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification and validation of a muscle failure index to predict prognosis and immunotherapy in lung adenocarcinoma through integrated analysis of bulk and single-cell RNA sequencing data.
    Gu X; Cai L; Luo Z; Shi L; Peng Z; Sun Y; Chen J
    Front Immunol; 2022; 13():1057088. PubMed ID: 36733390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.